Prophylactic treatment of anthrax with antibiotics: Indiscriminate use of antibiotics will lead to resistance in organisms

British Medical Journal

Volumn 323, Issue 7320, 2001, Pages 1017-1018

  Hart, C A ^a   Beeching, N J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTHRAX; ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; BACTERIAL MUTATION; BIOLOGICAL WARFARE; DISEASE CLASSIFICATION; EDITORIAL; HUMAN; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANTHRAX; ANTIBIOTIC PROPHYLAXIS; BIOTERRORISM; DRUG RESISTANCE, BACTERIAL; HUMANS; SYMBIOSIS;

EID: 0035802673     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Anthrax as a biological weapon
2. Postexposure prophylaxis against experimental anthrax
3. Fluoroquinolone-induced tendinopathy: What do we know?
4. Adverse reactions with fluoroquinolones
5. Fluoroquinolones in paediatrics
6. Emerging mechahisms of fluoroquinolone resistance
7. Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
8. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant Gram-negative bacilli from gastrointestinal flora
9. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal isolates of viridans group streptococci
10. Horizontal transfer of parC and gyrA fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
11. Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment
12. bmr3, a third multidrug transporter gene of Bacillus subtilis